Activation-dependent transcriptional regulation of the human fas promoter requires NF-κB p50-p65 recruitment

Molecular and Cellular Biology

Volumn 19, Issue 3, 1999, Pages 2098-2108

  Chan, Henry ^a   Bartos, David P ^a   Owen Schaub, Laurie B ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; FAS LIGAND; GUANINE NUCLEOTIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IONOMYCIN; MESSENGER RNA; PHORBOL 13 ACETATE 12 MYRISTATE; PHOSPHOPROTEIN; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR SP1;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; ELECTROPHORETIC MOBILITY; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENE INDUCTION; HUMAN; HUMAN CELL; IMMUNOLOGICAL TOLERANCE; LEUKEMIA CELL LINE; LYMPHOCYTE ACTIVATION; PRIORITY JOURNAL; PROMOTER REGION; SEQUENCE ANALYSIS; SITE DIRECTED MUTAGENESIS; TRANSCRIPTION REGULATION;

EID: 0033011889     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/mcb.19.3.2098     Document Type: Article

References (65)

1. Alderson, M. R., T. W. Tough, T. Davis-Smith, S. Braddy, B. Falk, K. A. Schooley, R. G. Goodwin, C. A. Smith, F. Ramsdell, and D. H. Lynch. 1995. Fas ligand mediates activation-induced cell death in human T lymphocytes. J. Exp. Med. 181:71-77.
2. + T cells from HIV-infected patients increases with disease progression. J. Mol. Med. 73:591-593.
3. Azizkhan, J. C., D. E. Jensen, A. J. Pierce, and M. Wade. 1993. Transcription from TATA-less promoters: dihydrofolate reductase as a model. Crit. Rev. Eukaryot. Gene Expr. 3:229-254.
4. Banda, N. K., J. Bernier, D. K. Kurahara, R. Kurrle, N. Haligwood, R. P. Sekaly, and T. H. Finkel. 1992. Crosslinking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis. J. Exp. Med. 176:1099-1106.
5. Behrmann, I., H. Walczak, and P. H. Krammer. 1994. Structure of the human APO-1 gene. Eur. J. Immunol. 24:3057-3062.
6. L. Immunity 3:87-98.
7. Boldin, M. P., T. M. G. Goncharou, Y. V. Goltsev, and D. Wallach. 1996. Involvement of MACH1, a novel MORT1/FADD interacting protease, in Fas/APO-1 and TNF receptor-induced cell death. Cell 85:803-815.
8. Briant, L., N. Coudronniere, V. Hebmann-Robert, M. Benkirane, and C. Devaux. 1996. Binding of HIV-1 virions or gp120-anti-gp120 immune complexes to HIV-1-infected quiescent peripheral blood mononuclear cells reveals latent infection. J. Immunol. 156:3994-4004.
9. Chen, J. L., L. D. Attardi, C. P. Verrijzer, K. Yokomori, and R. Tjian. 1994. Assembly of recombinant TFIID reveals differential coactivator requirements for distinct transcriptional activators. Cell 79:93-105.
10. Chen, Z., J. P. Hagler, V. F. Melandri, B. D. Scherer, and T. Maniatis. 1995. Signal-induced site-specific phosphorylation targets IκBα to the ubiquitin-proteasome pathway. Genes Dev. 9:1586-1597.
11. Chodish, L. A. 1989. DNA-protein interactions, p. 12.2.1-12.2.10. In F. M. Ausubel et al. (ed.), Current protocols in molecular biology, vol. 2. Greene Publishing Associates and Wiley-Interscience, New York, N.Y.
12. Courey, A. J., D. A. Holtzman, S. P. Jackson, and R. Tjian. 1989. Synergistic activation by the glutamine-rich domains of human transcription factor Sp1. Cell 59:827-836.
13. Debatin, K.-M., D. Süss, and P. H. Krammer. 1994. Differential expression of APO-1 on human thymocytes: implications for negative selection? Eur. J. Immunol. 24:753-758.
14. Dhein, J., H. Walczak, C. Bäumler, K. M. Debatin, and P. H. Krammer. 1995. Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature 373: 438-441.
15. Dignam, J., R. Lebovitz, and R. Roeder. 1983. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1475-1489.
16. Dinkel, A., W. K. Aicher, C. Haas, P. F. Zipfel, H.-H. Peter, and H. Eibel. 1997. Transcription factor Egr-1 activity down-regulates Fas and CD23 expression in B cells. J. Immunol. 159:2678-2684.
17. Drappa, J., N. Brot, and K. B. Elkon. 1993. The Fas protein is expressed at high levels on CD4+CD8+ thymocytes and activated mature lymphocytes in normal mice but not in the lupus-prone strain, MRL lpr/lpr. Proc. Natl. Acad. Sci. USA 90:10340-10344.
18. Fisher, G. H., F. J. Rosenberg, S. E. Straus, J. K. Dale, L. A. Middleton, A. Y. Lin, W. Strober, M. J. Lenardo, and J. M. Puck. 1995. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81:935-946.
19. Ghosh, G., G. V. Duyne, S. Ghosh, and P. B. Sigler. 1995. Structure of NF-κB p50 homodimer bound to a κB site. Nature 373:303-310.
20. Ghosh, S., M. J. May, and E. B. Kopp. 1998. NF-κB and Rel proteins: evolutionary conserved mediators of immune responses. Annu. Rev. Immunol. 16:225-260.
21. Hirano, F., H. Tanaka, Y. Hirano, M. Hiramoto, H. Handa, I. Makino, and C. Scheidereit. 1998. Functional interference of Sp1 and NF-κB through the same DNA binding site. Mol. Cell. Biol. 18:1266-1274.
22. Irmler, M., M. Thome, M. Hahne, P. Schneider, K. Hofmann, V. Steiner, J.-L. Bodmer, M. Schröter, K. Burns, C. Mattmann, D. Rimoldi, L. E. French, and J. Tschopp. 1997. Inhibition of death receptor signals by cellular FLIP. Nature 388:190-195.
23. Itoh, N., Y. Tsujimoto, and S. Nagata. 1993. Effect of bcl-2 or Fas antigen-mediated cell death. J. Immunol. 151:621-627.
24. Itoh, N., S. Yonehara, A. Ishii, M. Yonehara, S. Mizushima, M. Sameshima, A. Hase, Y. Seto, and S. Nagata. 1991. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66: 233-243.
25. 2 in breast carcinoma cells. Oncogene 10:2297-2305.
26. Ju, S. T., D. J. Panka, H. Cul, R. Ettinger, M. El-Khatib, D. H. Sherr, B. Z. Stanger, and A. Marshak-Rothstein. 1995. Fas (CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 373:444-448.
27. Katsikis, P. D., E. S. Wunderlich, C. A. Smith, L. A. Herzenberg, and L. A. Herzenberg. 1995. Fas antigen stimulation induces marked apoptosis of T lymphocytes in human immunodeficiency virus-infected individuals. J. Exp. Med. 181:2029-2036.
28. Kemper, O., and D. Wallach. 1993. Cloning and partial characterization of the promoter for the human p55 tumor necrosis factor (TNF) receptor. Gene 134:209-216.
29. Kruys, V., O. Marinx, G. Shaw, J. Deschamps, and G. Huez. 1989. Translational blockade imposed by cytokine-derived UA-rich sequences. Science 245:852-855.
30. Kunsch, C., S. M. Ruben, and C. A. Rosen. 1992. Selection of optimal κB/Rel DNA-binding motifs: interaction of both subunits of NF-κB with DNA is required for transcriptional activation. Mol. Cell. Biol. 12:4412-4421.
31. Kwon, H., N. Pelletier, C. DeLuca, P. Genin, S. Cisternas, R. Lin, M. A. Wainberg, and J. Hiscott. 1998. Inducible expression of IκBα repressor mutants interferes with NF-κB activity and HIV-1 replication in Jurkat T cells. J. Biol. Chem. 273:7431-7440.
32. Lai, J.-H., G. Horvath, J. Subleski, J. Bruder, P. Ghosh, and T.-H. Tan. 1995. RelA is a potent transcriptional activator of the CD28 response element within the interleukin 2 promoter. Mol. Cell. Biol. 15:4260-4271.
33. Leithäuser, F., J. Dhein, G. Mechtersheimer, K. Koretz, S. Brüderlein, C. Henne, A. Schmidt, K.-M. Debatin, P. H. Krammer, and P. Möller. 1993. Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells. Lab. Investig. 69:415-429.
34. Leverkus, M., M. Yaar, and B. A. Gilchrest. 1997. Fas/Fas ligand interaction contributes to UV-induced apoptosis in human keratinocytes. Exp. Cell Res. 232:255-262.
35. Locker, J. 1996. Transcription factors - essential data. John Wiley & Sons, Chichester, West Sussex, United Kingdom.
36. Marienfeld, R., M. Neumann, S. Chuvpilo, C. Escher, B. Kneitz, A. Avots, A. Schimpl, and E. Serfling. 1997. Cyclosporin A interferes with the inducible degradation of NF-κB inhihitors, but not with the processing of p105/NFκB1 in T cells. Eur. J. Immunol. 27:1601-1609.
37. Miyawaki, T., T. Uehara, R. Nibu, T. Tsuji, A. Yachie, S. Yonehara, and N. Taniguchi. 1992. Differential expression of apoptosis-related Fas antigen on lymphocyte subpopulations in human peripheral blood. J. Immunol. 149: 3753-3758.
38. Müller, C. W., F. A. Rey, M. Sodeoka, G. L. Verdine, and S. C. Harrison. 1995. Structure of the NF-κB p50 homodimer bound to DNA. Nature 373: 311-317.
39. Müller, M., S. Strand, H. Hug, E.-M. Heinemann, H. Walczak, W. J. Hoffmann, W. Stremmel, P. H. Krammer, and P. R. Galle. 1997. Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ ligand system and involves activation of wild-type p53. J. Clin. Investig. 99:403-413.
40. Muzio, M., A. M. Chinnaiyan, F. C. Kischkel, K. O'Rourke, A. Shevchenko, J. Ni, C. Scaffidi, J. D. Bretz, M. Zhang, R. Gentz, M. Mann, P. H. Krammer, M. E. Peter, and V. M. Dixit. 1996. FLICE, a novel FADD-homologous ICE/Ced-3-like protease, is recruited to the CD95 (Fas/APO-1) death inducing signaling complex. Cell 85:817-827.
41. Nagata, S. 1997. Apoptosis by death factor. Cell 88:355-365.
42. Neish, A. S., L. M. Khachigian, A. Park, V. R. Baichwal, and T. Collins. 1995. Sp1 is a component of the cytokine-inducible enhancer in the promoter of vascular cell adhesion molecule-1. J. Biol. Chem. 270:28903-28909.
43. Owen-Schaub, L. B., R. Radinsky, E. Kruzel, K. Berry, and S. Yonehara. 1994. Anti-Fas on nonhematopoietic tumors: levels of Fas/APO-1 and bcl-2 are not predictive of biological responsiveness. Cancer Res. 54:1580-1586.
44. Owen-Schaub, L. B., S. Yonehara, W. L. Crump, and E. A. Grimm. 1992. DNA fragmentation and cell death is selectively triggered in activated human lymphocytes by Fas antigen engagement. Cell. Immunol. 140:197-205.
45. Owen-Schaub, L. B., W. Zhang, J. C. Cusack, L. S. Angelo, S. M. Santee, T. Fujiwara, J. A. Roth, A. B. Deisseroth, W.-W. Zhang, E. Kruzel, and R. Radinsky. 1995. Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression. Mol. Cell. Biol. 15:3032-3040.
46. Pahl, H. L., B. Kraub, K. Schulze-Osthoff, T. Decker, E. B.-M. Traenckner, M. Vogt, C. Myers, T. Parks, P. Warring, A. Mühlbacher, A. P. Czernilofsky, and P. A. Baeuerle. 1996. The immunosuppressive fungal metabolite gliotoxin specifically inhibits transcription factor NF-κB. J. Exp. Med. 183:1829-1840.
47. Park, C. G., S. Y. Lee, G. Kandala, S. Y. Lee, and Y. Choi. 1996. A novel gene product that couples TCR signaling to Fas(CD95) expression in activation-induced cell death. Immunity 4:583-591.
48. Parry, G. C., and N. Mackman. 1994. A set of inducible genes expressed by activated human monocytic and endothelial cells contain κB-like sites that specifically bind c-Rel-p65 heterodimers. J. Biol. Chem. 269:20823-20825.
49. Pavletich, N. P., and C. O. Pabo. 1991. Zinc finger-DNA recognition: crystal structure of a Zif268-DNA complex at 2.1 Å. Science 252:809-817.
50. Perkins, N. D., N. L. Edwards, C. S. Duckett, A. B. Agranoff, R. M. Schmid, and G. J. Nabel. 1993. A cooperative interaction between NF-κB and Sp1 is required for HIV-1 enhancer activation. EMBO J. 12:3551-3558.
51. Rothe, J., H. Bluethmann, R. Gentz, W. Lesslauer, and M. Steinmetz. 1993. Genomic organization and promoter function of the murine tumor necrosis factor receptor Β gene. Mol. Immunol. 30:165-175.
52. Santee, S. M., and L. B. Owen-Schaub. 1996. Human tumor necrosis factor receptor p75/80 (CD120b) gene structure and promoter characterization. J. Biol. Chem. 271:21151-21159.
53. Sato, T., S. Irie, S. Kitada, and J. C. Reed. 1995. FAP-1: A protein tyrosine phosphatase that associates with Fas. Science 268:411-415.
54. Sehgal, A., N. Patil, and M. Chao. 1988. A constitutive promoter directs expression of the nerve growth factor receptor gene. Mol. Cell. Biol. 8:3160-3167.
55. Shaw, G., and R. Kamen. 1986. A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 46:659-667.
56. Sherka, C., E. L. Decker, and P. F. Zipfel. 1995. A regulatory element in the human interleukin 2 gene promoter is a binding site for the zinc finger proteins Sp1 and EGR-1. J. Biol. Chem. 270:22500-22506.
57. Sjottem, E., C. Andersen, and T. Johansen. 1997. Structural and functional analyses of DNA bending induced by Sp1 family transcription factors. J. Mol. Biol. 267:490-504.
58. Stein, B., A. S. Baldwin, Jr., D. W. Ballard, W. C. Greene, P. Angel, and P. Herrlich. 1993. Cross-coupling of the NF-κB p65 and Fos/Jun transcription factors produces potentiated biological function. EMBO J. 12:3879-3891.
59. Suzuki, I., and P. J. Fink. 1998. Maximal proliferation of cytotoxic T lymphocytes requires reverse signaling through Fas ligand. J. Exp. Med. 187: 123-128.
60. Takahashi, T., M. Tanaka, C. I. Brannan, N. A. Jenkins, N. G. Copeland, T. Suda, and S. Nagata. 1994. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76:969-976.
61. Tanaka, M., H. Ito, S. Adachi, H. Akimoto, T. Nishikawa, T. Kasajima, F. Marumo, and M. Hiroe. 1994. Hypoxia induces apoptosis with enhanced expression of Fas antigen messenger RNA in cultured neonatal rat cardiomyocytes. Circ. Res. 75:426-433.
62. Thanos, D., and T. Maniatis. 1992. The high mobility group protein HMG I(Y) is required for NF-κB-dependent virus induction of the human IFN-Β gene. Cell 71:777-789.
63. van Parijs, L., A. Ibraghimov, and A. K. Abbas. 1996. The roles of costimulation and Fas in T-cell apoptosis and peripheral tolerance. Immunity 4:321-326.
64. Verma, I. M., J. K. Stevenson, E. M. Schwartz, D. Van Antwerp, and S. Miyamoto. 1995. Rel/NF-κB/IκB family: intimate tales of association and dissociation. Genes Dev. 9:2723-2735.
65. Watanabe-Fukunaga, R., C. I. Brannan, N. G. Copeland, N. A. Jenkins, and S. Nagata. 1992. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356:314-317.